These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17029329)

  • 1. Special report: fecal DNA analysis for colon cancer screening.
    Technol Eval Cent Assess Program Exec Summ; 2006 Aug; 21(6):1-2. PubMed ID: 17029329
    [No Abstract]   [Full Text] [Related]  

  • 2. New test may detect colon cancer in earlier stages.
    McBride D
    ONS Connect; 2010 Oct; 25(10):18. PubMed ID: 21066961
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.
    Chen WD; Han ZJ; Skoletsky J; Olson J; Sah J; Myeroff L; Platzer P; Lu S; Dawson D; Willis J; Pretlow TP; Lutterbaugh J; Kasturi L; Willson JK; Rao JS; Shuber A; Markowitz SD
    J Natl Cancer Inst; 2005 Aug; 97(15):1124-32. PubMed ID: 16077070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update: non-invasive screening test for colon cancer; colonoscopy refined. These new findings may improve accuracy and subsequent treatment for colon cancer; some experts disagree.
    Duke Med Health News; 2011 Jan; 17(1):4. PubMed ID: 21313728
    [No Abstract]   [Full Text] [Related]  

  • 5. Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible?
    Brenner DE; Rennert G
    J Natl Cancer Inst; 2005 Aug; 97(15):1107-9. PubMed ID: 16077063
    [No Abstract]   [Full Text] [Related]  

  • 6. Colon cancer-associated DNA mutations: marker selection for the detection of proximal colon cancer.
    Berger BM; Robison L; Glickman J
    Diagn Mol Pathol; 2003 Dec; 12(4):187-92. PubMed ID: 14639104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal DNA for colorectal-cancer screening.
    Frossard JL; de Peyer R
    N Engl J Med; 2005 Mar; 352(13):1384-5; author reply 1384-5. PubMed ID: 15800239
    [No Abstract]   [Full Text] [Related]  

  • 8. Transcriptomic molecular markers for screening human colon cancer in stool and tissue.
    Ahmed FE; Vos P; iJames S; Lysle DT; Allison RR; Flake G; Sinar DR; Naziri W; Marcuard SP; Pennington R
    Cancer Genomics Proteomics; 2007; 4(1):1-20. PubMed ID: 17726236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals.
    Calistri D; Rengucci C; Casadei Gardini A; Frassineti GL; Scarpi E; Zoli W; Falcini F; Silvestrini R; Amadori D
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2647-54. PubMed ID: 20929882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon cancer screening strategies.
    Agrawal J; Syngal S
    Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fecal methylated DNA for the detection of colorectal cancer].
    von Delius S; Jung A; Schmid RM
    Z Gastroenterol; 2006 Sep; 44(9):1001-2. PubMed ID: 16981074
    [No Abstract]   [Full Text] [Related]  

  • 12. Summaries for patients. Stool DNA and occult blood testing to screen for colorectal neoplasia.
    Ann Intern Med; 2008 Oct; 149(7):I20. PubMed ID: 18838720
    [No Abstract]   [Full Text] [Related]  

  • 13. [DNA test as colon cancer screening. Hemoccult and colonoscopy are actually more reliable].
    Freitag MH
    MMW Fortschr Med; 2005 Apr; 147(16):10. PubMed ID: 16392392
    [No Abstract]   [Full Text] [Related]  

  • 14. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.
    Ahlquist DA; Skoletsky JE; Boynton KA; Harrington JJ; Mahoney DW; Pierceall WE; Thibodeau SN; Shuber AP
    Gastroenterology; 2000 Nov; 119(5):1219-27. PubMed ID: 11054379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue.
    Ahmed FE; Jeffries CD; Vos PW; Flake G; Nuovo GJ; Sinar DR; Naziri W; Marcuard SP
    Cancer Genomics Proteomics; 2009; 6(5):281-95. PubMed ID: 19996134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation biomarkers of stool and blood for early detection of colon cancer.
    Hong L; Ahuja N
    Genet Test Mol Biomarkers; 2013 May; 17(5):401-6. PubMed ID: 23406208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon cancer screening may change with DNA test.
    Mayo Clin Health Lett; 2001 Feb; 19(2):4. PubMed ID: 11216032
    [No Abstract]   [Full Text] [Related]  

  • 18. [Colonic carcinoma associated with ulcerative colitis. Risk factors, molecular pathogenesis and surveillance].
    Schürmann G; Ochman S; Neurath MF
    Dtsch Med Wochenschr; 2000 Sep; 125(36):1045-50. PubMed ID: 11022601
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of colon cancer screening.
    Lieberman D
    Am J Gastroenterol; 1991 Dec; 86(12):1789-94. PubMed ID: 1962624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
    N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.